Loading…
Synthesis, molecular modeling and preliminary biological evaluation of a set of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole as potential antibacterial, anti-Trypanosoma cruzi and antifungal agents
A novel set of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole has been synthesized and its antiprotozoal, antibacterial and antifungal activities evaluated. Also, their physicochemical and structural properties were explored to establish qualitative property-activity relationships. A series...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2011-11, Vol.19 (21), p.6292-6301 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A novel set of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole has been synthesized and its antiprotozoal, antibacterial and antifungal activities evaluated. Also, their physicochemical and structural properties were explored to establish qualitative property-activity relationships.
A series of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole derivatives was synthesized and their activity screened in vitro against Staphylococcus aureus, Trypanosoma cruzi, and Candida albicans. The bioactivity was expressed as minimum inhibitory concentration (MIC) for S. aureus strains, and as fifty-percent inhibitory concentration (IC50) of parasite population growth for T. cruzi. A molecular modeling approach was performed to establish qualitative relationships regarding the biological data and the compounds’ physicochemical properties. The 5-(4-OC4H9Ph, 5l), and 5-(4-CO2CH3Ph, 5o) derivatives were the most active compounds for S. aureus ATCC 25923 (MIC=1.95–1.25μg/mL) and T. cruzi (IC50=7.91μM), respectively. Also, a preliminary evaluation against C. albicans involving some compounds was performed and the 5-(4-CH3Ph, 5e) derivative was the most active compound (MIC=3.28–2.95μg/mL). In this preliminary study, all synthesized 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole derivatives were active against all microorganisms tested. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2011.09.009 |